Taiwan FDA registration c7289bebeb2b6c6f1d3535608d1f3c36
Glucose Measurement Stable Jiukang Blood Glucose Test System
TW: 測糖穩久康血糖測試系統
Taiwan·Risk Class 2·LEISON BIOTECH CO., LTD.·Registered Oct 27, 2021 – Oct 27, 2026ActiveRegistration details
- Analysis ID
- c7289bebeb2b6c6f1d3535608d1f3c36
Company information
- Manufacturer
- LEISON BIOTECH CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- LEISON BIOTECH CO., LTD.
Product details
- Intended Use
- For in vitro testing to quantitatively measure glucose concentration in fresh microvascular blood and venous whole blood samples for professional use and user self-testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Oct 27, 2021
- Expiry Date
- Oct 27, 2026
About this record
Access comprehensive regulatory information for Glucose Measurement Stable Jiukang Blood Glucose Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c7289bebeb2b6c6f1d3535608d1f3c36 and manufactured by LEISON BIOTECH CO., LTD.. The authorized representative in Taiwan is LEISON BIOTECH CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices